Literature DB >> 21356347

BMP-6 emerges as a potential major regulator of fibrosis in the kidney.

Robert H Jenkins1, Donald J Fraser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21356347      PMCID： PMC3069840          DOI： 10.1016/j.ajpath.2010.12.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  14 in total

1.  BMP4 substitutes for loss of BMP7 during kidney development.

Authors:  Leif Oxburgh; Andrew T Dudley; Robert E Godin; Chad H Koonce; Ayesha Islam; Dorian C Anderson; Elizabeth K Bikoff; Elizabeth J Robertson
Journal:  Dev Biol       Date:  2005-09-08       Impact factor: 3.582

Review 2.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 3.  How the Smads regulate transcription.

Authors:  Sarah Ross; Caroline S Hill
Journal:  Int J Biochem Cell Biol       Date:  2007-10-07       Impact factor: 5.085

4.  BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.

Authors:  G Luo; C Hofmann; A L Bronckers; M Sohocki; A Bradley; G Karsenty
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

5.  Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

Authors:  Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

Authors:  Michael Zeisberg; Cindy Bottiglio; Navin Kumar; Yohei Maeshima; Frank Strutz; Gerhard A Müller; Raghu Kalluri
Journal:  Am J Physiol Renal Physiol       Date:  2003-08-12

Review 7.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

8.  Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.

Authors:  Hikaru Sugimoto; Gordan Grahovac; Michael Zeisberg; Raghu Kalluri
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

9.  Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.

Authors:  Dong Dong Luo; Aled Phillips; Donald Fraser
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

10.  Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

Authors:  Shinong Wang; Raimund Hirschberg
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157
View more
  5 in total

1.  MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney.

Authors:  Jianyin Long; Shawn S Badal; Yin Wang; Benny H J Chang; Antony Rodriguez; Farhad R Danesh
Journal:  J Biol Chem       Date:  2013-10-25       Impact factor: 5.157

2.  The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development.

Authors:  Sonya Nassari; Cédrine Blavet; Marie-Ange Bonnin; Sigmar Stricker; Delphine Duprez; Claire Fournier-Thibault
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

3.  Ultra structural changes occurring in duct ectasia and periductal mastitis and their significance in etiopathogenesis.

Authors:  Kirithiga Ramalingam; Seenu Vuthaluru; Anurag Srivastava; Amit Kumar Dinda; Anita Dhar
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

Review 4.  Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.

Authors:  Xiaojun Li; Shougang Zhuang
Journal:  Fibrogenesis Tissue Repair       Date:  2014-10-02

5.  Reduced expression of BMP3 contributes to the development of pulmonary fibrosis and predicts the unfavorable prognosis in IIP patients.

Authors:  Xiaoting Yu; Pan Gu; Ziling Huang; Xia Fang; Ying Jiang; Qun Luo; Xia Li; Xuyou Zhu; Mengna Zhan; Junbang Wang; Lichao Fan; Rongchang Chen; Juehua Yu; Yingying Gu; Aibin Liang; Xianghua Yi
Journal:  Oncotarget       Date:  2017-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.